March is National Kidney Month – a time to raise awareness and learn more about kidney health and kidney disease. Earlier in 2025, the U.S. Food and Drug Administration (FDA) approved Ozempic ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...

By increasing muscle loss and decreasing cardiorespiratory fitness, weight-loss drugs can negatively affect mortality risk, ...

Novo Nordisk A/S: Ozempic® receives EU recommendation in peripheral arterial disease, cementing the broad benefits of semaglutide for people with type 2 diabetes and comorbidities Published ...

Too often, patients with chronic kidney disease get diagnosed too late – if at all. Addressing risk factors early can stave off the disease’s worst effects.

The Kidney Disease: Improving Global Outcomes (KDIGO) group has updated chronic kidney disease treatment guidelines to help slow disease progression in adults. A JAMA article published Wednesday ...